23 completed, 3 terminated, 2 unknown, 1 enrolling by invitation. 30 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 30 | Completed 23, Terminated 3, Unknown 2, Enrolling by invitation 1, Withdrawn 1 |
Follow avastin: new trials by email Literature Review of avastin trials Research Report on avastin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria Atezolizumab, Bevacizumab - Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 4 | Enrolling by invitation | The Methodist Hospital Research Institute | 24 | 2023-01-30 | 2026-10-08 |
| Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema Intravitreal ranibizumab, Intravitreal bevacizumab - Diabetic Macular Edema, Macular Ischemia | Phase 4 | Terminated | Cairo University | 5 | 2021-11-26 | 2023-02-16 |
| Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy Bevacizumab Injection, Targeted retinal photocoagulation, Standard pan-retinal photocoagulation - Proliferative Diabetic Retinopathy, Vascular Endothelial Growth Factor Overexpression | Phase 4 | Completed | Cairo University | 43 | 2021-03-30 | 2024-01-19 |
| An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Bevacizumab - Ovarian Neoplasms, Peritoneal Neoplasms | Phase 4 | Completed | Hoffmann-La Roche | 100 | 2018-12-05 | 2025-06-26 |
| Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification Bevacizumab, Ranibizumab, Aflibercept - Diabetic Macular Edema, Cataract | Phase 4 | Completed | Bay Area Retina Associates | 16 | 2018-11-15 | 2025-09-12 |
| Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA Bevacizumab - Diabetic Macular Edema, Ischemic Maculopathy | Phase 4 | Completed | Cairo University | 31 | 2017-10-23 | 2020-01-30 |
| Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO Dexamethasone intravitreal implant, Bevacizumab Injectable Product - Diabetic Macular Edema, Diabetic Retinopathy | Phase 4 | Completed | Lions Eye Institute, Perth, Western Australia | 59 | 2017-02-07 | 2020-11-09 |
| Strategies for Management of Recurrent Pterygium Bevacizumab, 5 fluorouracil - Recurrent Pterygium | Phase 4 | Unknown | University of Nottingham | 25 | 2017-01-01 | 2017-11-14 |
| Intranasal Bevacizumab for HHT-Related Epistaxis Bevacizumab, Placebo (Saline) - HHT, Hereditary Hemorrhagic Telangiectasia | Phase 4 | Completed | Stanford University | 40 | 2014-08-04 | 2021-09-01 |
| Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema Ozurdex, Bevacizumab - Diabetic Macular Edema | Phase 4 | Completed | Raj K. Maturi, MD | 45 | 2014-01-01 | 2015-12-01 |
| Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases avastin, mFOLFOX6 - Colorectal Neoplasms | Phase 4 | Completed | Xu jianmin | 241 | 2013-10-01 | 2019-12-17 |
| Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab gemcitabine, cisplatin and bevacizumab - Non-Small Cell Lung Cancer (NSCLC) | Phase 4 | Completed | Fundacion Clinic per a la Recerca Biomédica | 19 | 2013-07-01 | 2016-10-05 |
| Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema Bevacizumab - Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy | Phase 4 | Completed | King Khaled Eye Specialist Hospital | 50 | 2013-06-01 | 2021-12-03 |
| A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer 5-FU based doublet chemotherapy, bevacizumab - Colorectal Cancer | Phase 4 | Completed | Hoffmann-La Roche | 50 | 2012-10-16 | 2017-06-09 |
| Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab Bevacizumab, Paclitaxel, Carboplatin - Ovarian Cancer | Phase 4 | Unknown | National Cancer Institute, Naples | 400 | 2012-10-01 | 2023-03-24 |
| Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy intravitreal injection of bevacizumab - Vitreous Hemorrhage, Proliferative Diabetic Retinopathy | Phase 4 | Completed | Khon Kaen University | 18 | 2012-08-01 | 2013-04-26 |
| An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study Bevacizumab - Neoplasms | Phase 4 | Completed | Hoffmann-La Roche | 95 | 2012-07-13 | 2020-11-05 |
| Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy Bevacizumab, Vitrectomy, Sham injection - Proliferative Diabetic Retinopathy, Diabetic Traction Retinal Detachment | Phase 4 | Completed | Nihon University | 69 | 2012-05-01 | 2014-07-14 |
| Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema Bevacizumab, dexamethasone intravitreal implant - Diabetic Macular Edema | Phase 4 | Completed | Maturi, Raj K., M.D., P.C. | 40 | 2011-03-01 | 2014-10-29 |
| Use of Bevacizumab in Trabeculectomy Surgery Bevacizumab, Control - Glaucoma, Optic Neuropathy | Phase 4 | Completed | Sunnybrook Health Sciences Centre | 59 | 2010-06-01 | 2023-08-21 |
Showing 20 of 30. Sign in to see all of them.
Colorectal Neoplasms (5) · Diabetic Retinopathy (4) · Breast Neoplasms (2) · Glaucoma (2) · Macular Edema (2) · Ovarian Neoplasms (2) · Vitreous Hemorrhage (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Cataract (1) · Epistaxis (1) · Fallopian Tube Neoplasms (1) · Fibrosis (1) · Liver Neoplasms (1) · Macular Degeneration (1)
Hoffmann-La Roche (6) · Cairo University (3) · Maturi, Raj K., M.D., P.C. (2) · Bay Area Retina Associates (1) · Fundacion Clinic per a la Recerca Biomédica (1) · Genentech, Inc. (1) · Hospices Civils de Lyon (1) · Khon Kaen University (1) · King Khaled Eye Specialist Hospital (1) · Lions Eye Institute, Perth, Western Australia (1) · Medical University of Vienna (1) · National Cancer Institute, Naples (1) · Nihon University (1) · Nova Scotia Health Authority (1) · Oslo University Hospital (1)
United States (7) · Canada (4) · Egypt (3) · Austria (2) · Brazil (2) · China (2) · France (2) · Italy (2) · Spain (2) · United Kingdom (2) · Australia (1) · Bulgaria (1) · Czechia (1) · Estonia (1) · Germany (1)
Raj K Maturi, MD (3) · Ahmed A Abdel-Kader, MD, PhD (2) · Ahmed A Mohalhal, MD, PhD (2) · Ayman G Elnahry, MD, PhD (2) · Ahmed AA Abdel Kader, PhD (1) · Andreas Moan (1) · Angus Turner, FRANZCO (1) · Ayman GA Elnahry, MSc (1) · Ayumu Manabe (1) · Caesar Luo, MD (1) · Catherine Birt, MD, FRCSC (1) · Ciro Gallo, M.D. (1) · Francesco Perrone, M.D., Ph.D. (1) · Gennaro Daniele, M.D., Ph.D. (1)
PMID 32411431, PMID 31139483, PMID 32427087, PMID 20416952, PMID 22080911, PMID 22176513, PMID 22250209, PMID 22330964, PMID 24768239, PMID 25892934, PMID 26338819, PMID 26565927, PMID 26605370, PMID 26903223, PMID 28114569, PMID 28168567, PMID 29080915, PMID 31227330, PMID 32584384, PMID 32749938, PMID 33206392, PMID 33784213, PMID 33931498, PMID 34124270, PMID 34189816, PMID 34462317, PMID 34498344, PMID 3523356, PMID 39415516, PMID 42575837, PMID 6182936, PMID 6521986
2009 (1)